Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review
Authors
Keywords
BMD, Bone turnover markers, Diabetes, Fracture, Oral anti-diabetic drugs, Osteoporosis
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 26, Issue 8, Pages 2073-2089
Publisher
Springer Nature
Online
2015-04-24
DOI
10.1007/s00198-015-3123-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trabecular Bone Score as an Indicator for Skeletal Deterioration in Diabetes
- (2015) Jung Hee Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Possible adverse effects of SGLT2 inhibitors on bone
- (2015) Simeon I Taylor et al. Lancet Diabetes & Endocrinology
- DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats
- (2014) Lorenzo Glorie et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
- (2014) Zhong-Ning Zhu et al. BONE
- Fracture risk in diabetic elderly men: the MrOS study
- (2014) Nicola Napoli et al. DIABETOLOGIA
- SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats
- (2014) Masanori Yokono et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
- (2014) María Laura Sbaraglini et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of glimepiride on the skeletal system of ovariectomized and non-ovariectomized rats
- (2014) Justyna Fronczek-Sokół et al. Pharmacological Reports
- Treatment Effects on Measures of Body Composition in the TODAY Clinical Trial
- (2013) DIABETES CARE
- High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control: The Rotterdam Study
- (2013) L. Oei et al. DIABETES CARE
- Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
- (2013) G. A. Bray et al. DIABETES OBESITY & METABOLISM
- Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione
- (2013) T. Cusick et al. DIABETES OBESITY & METABOLISM
- Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin
- (2013) María José Tolosa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
- (2013) Emily Jane Gallagher et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
- (2013) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Is There a Role for Laparoscopic Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma? A Critical Appraisal of the Literature
- (2013) C. Jurowich et al. HORMONE AND METABOLIC RESEARCH
- Nonclinical Toxicology Assessments Support the Chronic Safety of Dapagliflozin, a First-in-Class Sodium-Glucose Cotransporter 2 Inhibitor
- (2013) Mark Tirmenstein et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
- (2013) Xue Ma et al. JOURNAL OF BONE AND MINERAL RESEARCH
- In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
- (2013) Joshua N Farr et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus
- (2013) John P. Bilezikian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
- (2013) Guillaume Mabilleau et al. JOURNAL OF ENDOCRINOLOGY
- Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
- (2013) Ju-Young Kim et al. LIFE SCIENCES
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
- (2013) J. Jeyabalan et al. OSTEOPOROSIS INTERNATIONAL
- Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系：一项对随机临床试验的meta分析)
- (2013) Guillaume Mabilleau et al. Journal of Diabetes
- Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line
- (2013) M. Salai et al. Bone & Joint Journal
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration
- (2012) Lichu Liu et al. BONE
- Risk of Fracture with Thiazolidinediones: Disease or Drugs?
- (2012) Marloes T. Bazelier et al. CALCIFIED TISSUE INTERNATIONAL
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
- (2012) Paul A. Dutchak et al. CELL
- Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
- (2012) Ö. Ljunggren et al. DIABETES OBESITY & METABOLISM
- Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes
- (2012) S. S. Johnston et al. DIABETES OBESITY & METABOLISM
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial
- (2012) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
- (2012) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies
- (2012) Lili Ma et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism
- (2012) Aleksandra Mieczkowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice
- (2012) Chun Wang et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Protective Effect of Metformin on Periapical Lesions in Rats by Decreasing the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin
- (2012) Lingshuang Liu et al. JOURNAL OF ENDODONTICS
- Effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone mesenchymal stem cells into adipocytes
- (2012) Linfang Wang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption
- (2012) Eui-Sic Cho et al. MOLECULES AND CELLS
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes
- (2012) George R. Beck et al. Translational Research
- Rosiglitazone Decreases Plasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes Patients
- (2011) Mads Nybo et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis
- (2011) L. D. Sardone et al. DIABETES
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
- (2011) J. L. C. Borges et al. DIABETES OBESITY & METABOLISM
- Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
- (2011) Claudia Sedlinsky et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rosiglitazone and Pioglitazone Inhibit Estrogen Synthesis in Human Granulosa Cells by Interfering with Androgen Binding to Aromatase
- (2011) D. Seto-Young et al. HORMONE AND METABOLIC RESEARCH
- AICAR, a Small Chemical Molecule, Primes Osteogenic Differentiation of Adult Mesenchymal Stem Cells
- (2011) Wei Wu et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- FRAX underestimates fracture risk in patients with diabetes
- (2011) Lora M Giangregorio et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats
- (2011) Qi-Guang Mai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Rosiglitazone Decreases Bone Mass and Bone Marrow Fat
- (2011) Torben Harsløf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
- (2011) Bernardo Nuche-Berenguer et al. JOURNAL OF ENDOCRINOLOGY
- Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*
- (2011) Mathijs C. BUNCK et al. Journal of Diabetes
- Extrapancreatic roles of glimepiride on osteoblasts from rat manibular bone in vitro: Regulation of cytodifferentiation through PI3-kinases/Akt signalling pathway
- (2010) Pan Ma et al. ARCHIVES OF ORAL BIOLOGY
- Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2
- (2010) Won Gu Jang et al. BONE
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
- (2010) Ugis Gruntmanis et al. CALCIFIED TISSUE INTERNATIONAL
- ORIGINAL ARTICLE: Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study
- (2010) Zehra Berberoglu et al. CLINICAL ENDOCRINOLOGY
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
- (2010) M. C. Bunck et al. DIABETES OBESITY & METABOLISM
- Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression
- (2010) G. Mabilleau et al. DIABETIC MEDICINE
- Thiazolidinediones and fracture risk in patients with Type 2 diabetes
- (2010) D. J. Betteridge DIABETIC MEDICINE
- Differential Effects of PPAR-γ ActivationversusChemical or Genetic Reduction of DPP-4 Activity on Bone Quality in Mice
- (2010) Kimberly A. Kyle et al. ENDOCRINOLOGY
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
- (2010) Ying Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus
- (2010) Ippei Kanazawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- IGF-1 and bone: New discoveries from mouse models
- (2010) Shoshana Yakar et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
- (2010) Bernardo Nuche-Berenguer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus
- (2010) Andrew J. Burghardt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus
- (2010) I. Kanazawa et al. OSTEOPOROSIS INTERNATIONAL
- Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy
- (2010) U. Krause et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow
- (2009) C. Sanz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Thiazolidinediones and Fractures in Men and Women
- (2009) Colin R. Dormuth et al. ARCHIVES OF INTERNAL MEDICINE
- Four-month treatment with GLP-2 significantly increases hip BMD
- (2009) Dennis B. Henriksen et al. BONE
- Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
- (2009) Tatiana Mancini et al. BONE
- Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
- (2009) Bernardo Nuche-Berenguer et al. CALCIFIED TISSUE INTERNATIONAL
- Thiazolidinedione use and the risk of fractures
- (2009) K. A. Toulis et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis
- (2009) B. Gustafson et al. DIABETOLOGIA
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes
- (2009) Hong Li et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
- (2009) M Silvina Molinuevo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells
- (2009) Keith R. Shockley et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoblast differentiation is functionally associated with decreased AMP kinase activity
- (2009) Takayuki Kasai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
- (2009) Ann V. Schwartz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
- (2009) Daniel H. Solomon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Metformin reverses the deleterious effects of high glucose on osteoblast function
- (2009) Donghu Zhen et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway
- (2009) Pan Ma et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
- (2009) Unni Syversen et al. BMC Endocrine Disorders
- The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
- (2009) Ian J. Douglas et al. PLOS MEDICINE
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression
- (2008) Ippei Kanazawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Risk Factors for Fractures and Falls in Older Women with Type 2 Diabetes Mellitus
- (2008) Sanjeev Patel et al. CALCIFIED TISSUE INTERNATIONAL
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Metformin Reverts Deleterious Effects of Advanced Glycation End-Products (AGEs) on Osteoblastic Cells
- (2008) L. Schurman et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
- (2008) L Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
- (2008) Dorte Glintborg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome
- (2008) Ida B. Gottschalck et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
- (2007) Chizumi Yamada et al. ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started